Motus GI up on FDA nod for next-gen Pure-Vu

Thinly traded nano cap Motus GI Holdings (NASDAQ:MOTS) is up 21% premarket on increased volume in reaction to its announcement that the FDA has granted 510(k) clearance for its next-generation Pure-Vu System used to facilitate the cleaning of a poorly prepared colon during a colonoscopy.

https://seekingalpha.com/news/3470375-motus-gi-21-percent-premarket-fda-nod-next-gen-pure-vu